Deiringer Natalie, Fischer Fabian, Hofsäss Martin, Ranft Meik, Ebert Sophia
BASF SE, Carl-Bosch-Strasse 38, 67056 Ludwigshafen am Rhein, Germany.
BASF SE, Carl-Bosch-Strasse 38, 67056 Ludwigshafen am Rhein, Germany.
Eur J Pharm Biopharm. 2025 Feb;207:114628. doi: 10.1016/j.ejpb.2025.114628. Epub 2025 Jan 10.
Poloxamer 338 is used as versatile thermo-responsive gelling agent in topical and sub-cutaneous applications. Due to application specific needs a gel point below body or even below room temperature is required. The influence of inorganic salts and active pharmaceutical ingredients (APIs) on the gel point was investigated using oscillatory rheology to identify the driving forces and predictors for gel point alteration. While most inorganic salts decreased the gel point, API salts exhibited an increase. Consistent with previous findings, the extent of gel point alteration caused by inorganic salts could be empirically described by the Hofmeister series, primarily influenced by the anion. Notably, this study revealed a concentration-dependent increase in the gel point in the presence of API salts. Moreover, this increase could be accurately predicted in a linear manner by considering the respective logP value. By utilizing the proposed prediction model, the effect of API addition on the gel point can be estimated, facilitating formulation development to achieve the desired gelling behavior for specific applications.
泊洛沙姆338在局部和皮下应用中用作通用的热响应性凝胶剂。由于特定应用的需求,需要凝胶点低于体温甚至低于室温。使用振荡流变学研究了无机盐和活性药物成分(API)对凝胶点的影响,以确定凝胶点改变的驱动力和预测因素。虽然大多数无机盐会降低凝胶点,但API盐却会使其升高。与先前的研究结果一致,无机盐引起的凝胶点改变程度可以根据霍夫迈斯特序列进行经验性描述,主要受阴离子影响。值得注意的是,本研究揭示了在存在API盐的情况下凝胶点呈浓度依赖性增加。此外,通过考虑各自的logP值,可以以线性方式准确预测这种增加。通过使用所提出的预测模型,可以估计添加API对凝胶点的影响,有助于制剂开发,以实现特定应用所需的凝胶行为。